Gastric Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Sep 15, 2004; 10(18): 2624-2627
Published online Sep 15, 2004. doi: 10.3748/wjg.v10.i18.2624
Table 1 VEGF expression in NMNCE, ANCE and gastric carcinoma (n = 73)
Tissue originnVEGF expression
Positive rate (%)
-+
NMNCE73730-
ANCE73235068.5b
Gastric carcinoma73145980.81
Table 2 Relationship between VEGF expression and gross and histological types of gastric carcinoma (n = 73)
TypenVEGF expression
Positive rate (%)
-+
Gross types
EGCa2481666.7
I404100.0
II126650.0
III72571.4
SS1101100.0
AGC4964387.8
Bor. 0303100.0
Bor. I101100.0
Bor. II606100.0
Bor. III3653186.1
Bor. IV31266.7
Histological type
Papillary adenocarcinoma81787.5
Well-differentiated adenocarcinoma32133.3
Moderately-differentiated adenocarcinoma113872.7
Poorly-differentiated adenocarcinoma3052583.3
Undifferentiated carcinoma31266.7
Signet-ring cell carcinoma101990.0
Mucinous adenocarcinoma707100.0
Carcinoid110-
Table 3 Relationship between VEGF expression and metastasis of gastric carcinoma (n = 73)
Metastasis statusnVEGF expression
Positive rate (%)
-+
No metastasis32122062.5b
Lymph node metastasis3943589.7
Liver metastasis1100
Ovary metastasis101100.0
Table 4 VEGF and Maspin expressions in NMNCE, GNEIM and gastric carcinoma
Histological typenVEGF
+%Maspin
+%
+-+-
NMNCE39039016a2341.0
GNEIM14---140100.0
Gastric carcinoma
Papillary adenocarcinoma330100.02166.7
Well-differentiated adenocarcinoma32166.72166.7
Moderately-differentiated adenocarcinoma65183.32433.3
Poorly-differentiated adenocarcinoma2114766.7111052.4
Undifferentiated adenocarcinoma32166.71233.3
Signet ring-cell carcinoma32166.72166.7
Total of gastric carcinoma39281171.8201951.3
Table 5 Relationship between VEGF and Maspin expressions in gastric carcinoma
Gastric carcinomaMaspin +Maspin -Total
VEGF +151328
VEGF -5611
Total201939